STERIS plc (STE)
NYSE: STE · Real-Time Price · USD
209.62
-0.53 (-0.25%)
Jan 17, 2025, 4:00 PM EST - Market closed
STERIS Employees
STERIS had 18,179 employees as of March 31, 2024. The number of employees increased by 1,079 or 6.31% compared to the previous year.
Employees
18,179
Change (1Y)
1,079
Growth (1Y)
6.31%
Revenue / Employee
$292,949
Profits / Employee
$23,918
Market Cap
20.69B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 18,179 | 1,079 | 6.31% |
Mar 31, 2023 | 17,100 | 678 | 4.13% |
Mar 31, 2022 | 16,422 | 3,652 | 28.60% |
Mar 31, 2021 | 12,770 | 411 | 3.33% |
Mar 31, 2020 | 12,359 | 359 | 2.99% |
Mar 31, 2019 | 12,000 | 0 | - |
Mar 31, 2018 | 12,000 | 0 | - |
Mar 31, 2017 | 12,000 | -2,000 | -14.29% |
Mar 31, 2016 | 14,000 | 6,400 | 84.21% |
Mar 31, 2015 | 7,600 | 1,600 | 26.67% |
Mar 31, 2014 | 6,000 | 0 | - |
Mar 31, 2013 | 6,000 | 1,000 | 20.00% |
Mar 31, 2012 | 5,000 | 0 | - |
Mar 31, 2011 | 5,000 | 0 | - |
Mar 31, 2010 | 5,000 | 0 | - |
Mar 31, 2009 | 5,000 | -300 | -5.66% |
Mar 31, 2008 | 5,300 | 200 | 3.92% |
Mar 31, 2007 | 5,100 | 0 | - |
Mar 31, 2006 | 5,100 | -150 | -2.86% |
Mar 31, 2005 | 5,250 | 150 | 2.94% |
Mar 31, 2004 | 5,100 | 0 | - |
Mar 31, 2003 | 5,100 | 604 | 13.43% |
Mar 31, 2002 | 4,496 | -91 | -1.98% |
Mar 31, 2001 | 4,587 | -223 | -4.64% |
Mar 31, 2000 | 4,810 | 66 | 1.39% |
Mar 31, 1999 | 4,744 | 244 | 5.42% |
Mar 31, 1998 | 4,500 | 500 | 12.50% |
Mar 31, 1997 | 4,000 | 3,440 | 614.29% |
Mar 31, 1996 | 560 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
STE News
- 2 months ago - Steris Q2: Anticipating HSD Growth In AST, Upgrade To 'Buy' - Seeking Alpha
- 2 months ago - STERIS plc (STE) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Steris beats quarterly estimates on continued demand for medical procedures - Reuters
- 2 months ago - STERIS Announces Financial Results for Fiscal 2025 Second Quarter - GlobeNewsWire
- 2 months ago - STERIS Declares Dividend of $0.57 per share - GlobeNewsWire
- 3 months ago - STERIS to Host a Conference Call for Fiscal 2025 Second Quarter Financial Results on November 7, 2024 - GlobeNewsWire
- 3 months ago - STERIS plc (STE) Enters New $1.1 Billion Revolving Credit Agreement - GuruFocus
- 5 months ago - 15 Upcoming Dividend Increases Including A King - Seeking Alpha